Keywords : Anemia and obstetric haemorrhage
TRANSFUSION OF BLOOD AND BLOOD PRODUCTS IN OBSTETRICS AT A TERTIARY CARE HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 5, Pages 8-15
Background: Anemia and obstetric haemorrhage are major causes of maternal mortality. Both of those are the commonest indications requiring blood and component transfusion. Blood transfusion is a crucial component of comprehensive emergency obstetric care. This study was aimed to explore indications for blood and blood component transfusion in obstetrics.
Methods: This prospective observational study was carried out from January 2022 to June 2022 at a tertiary care hospital in Department of Obstetrics and Gynecology. Data was gathered from all patients who underwent transfusion of blood and/or blood products for any obstetric issue.
Results: During the study period, total 200 patients were transfused with blood and/or blood components. Two most common indications for blood transfusion were obstetric haemorrhage (64.5%) and anemia (43%). 180 patients were given PCV (90%), 80 patients received FFP (40%), 86 received PRC (43%) and 12 received cryoprecipitate (6%).
Conclusion: Maintaining a proper transfusion schedule, keeping transfusion minimum and, only using when absolutely indicated, may make blood transfusion safer and more effective. Awareness about blood donation should be increased.